MicroRNA-135a-induced formation of CD133+subpopulation with cancer stem cell properties in cervical cancer

Carmen O.N. Leung, Wen Deng, Tian Min Ye, Hextan Y.S. Ngan, Sai Wah Tsao, Annie N.Y. Cheung, Niu Ziru, Dominic C.K. Yuen, Ronald T.K. Pang, William S.B. Yeung

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) play significant roles in tumor initiation. MicroRNA-135a (miR-135a) induced the formation of a CD133+ subpopulation from a human papillomavirus-immortalized cervical epithelial cell line. Compared with the CD133- cells, the CD133+ cells expressed higher levels of miR-135a and OCT4, exhibited significantly higher tumorsphere forming capacity and the time required for tumorsphere formation was shortened in the second generation. Serum induction suppressed the expression of CD133, OCT4 and miR-135a, but increased expression of involucrin in the miR-135a-induced CD133+ cells. The miR-135a-induced CD133+ cells were tumorigenic in a limiting dilution approach in vivo. The cells expressed significantly higher level of active β-catenin and OCT4 than the CD133- counterpart. Wnt3a enhanced the expression of OCT4 and CD133 in cervical cancer cells but failed to enhance CD133 transcription in normal cervical cells. Wnt3a stimulation also increased tumorsphere size and self-renewal of miR-135a-induced CD133+ subpopulation. Wnt/β-catenin inhibition suppressed tumorsphere formation while Wnt3a partially nullified the inhibitory effect. Taken together, miR-135a induced the formation of a subpopulation of cells with CSC properties both in vitro and in vivo and the Wnt/β-catenin signaling pathway is essential to maintain its tumorigenicity.

Original languageEnglish
Pages (from-to)1592-1604
Number of pages13
JournalCarcinogenesis
Volume41
Issue number11
DOIs
Publication statusPublished - 1 Nov 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'MicroRNA-135a-induced formation of CD133+subpopulation with cancer stem cell properties in cervical cancer'. Together they form a unique fingerprint.

Cite this